Search companies or stocks...
OCSOculis Holding AG
At close · 25 Aug 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Oculis Holding AG, a clinical-stage biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. The company's…
Current stock price of Oculis Holding AG (OCS) stock is $12.960. The stock price is -1.67% lower in the session. The intraday range can be seen from this page. Volume of Oculis Holding AG (OCS) stock is 76.44K.
Last updated at 25 Aug 2026, 08:00 pm.
The stock price of Oculis Holding AG (OCS) can change with earnings, company news, and overall market sentiment. Oculis Holding AG operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Oculis Holding AG looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for OCS on this page is -7.45. EPS on this page is -1.74. Compare those figures with peers and growth expectations before deciding if the current Oculis Holding AG price is justified.
Historical performance for Oculis Holding AG (OCS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how OCS reacted to past earnings and market events.
Buying Oculis Holding AG (OCS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
